Literature DB >> 12800945

Epidemiology of essential hypertension: the role of genetic polymorphism.

V Romano-Spica1, M Mettimano, A Ianni, M L Specchia, G Ricciardi, L Savi.   

Abstract

Over the past 20 years, the interest of the scientific community was increasingly placed in the field of genetic epidemiology and molecular genetics of blood pressure control. This paper explores references related to essential hypertension, gene and genetic epidemiology indexed in the MedLine health science database during the period 1980-2001. A systematic literature search was performed using selected keywords, such as 'genetic', 'genome' or a combination of words. We considered the study heading and evaluated the time profile of published articles. A total number of 3116 publications was collected and analyzed. Allelic distribution for the most studied polymorphisms of the renin-angiotensin system in different world populations was reviewed and reported together with a detection of their frequency in Italy: essential hypertensive patients (n = 90), healthy unrelated subjects (n = 300). Molecular variants at angiotensinogen (M and T), angiotensin II type 1 receptor (A and C) and angiotensin-converting enzyme (D and I) genes were analyzed by amplified fragment length polymorphism. A significant association was detected by chi2 analysis for angiotensinogen and angiotensin II-type I receptor allele distribution in hypertensive patients, in accordance with previous reports. Genetic data and methods are contributing more and more to epidemiological studies of complex diseases, and their application is influenced by information availability and Genome Project results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12800945     DOI: 10.1023/A:1023360410810

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  41 in total

1.  Evaluating hypertension control in a managed care setting.

Authors:  M Alexander; I Tekawa; E Hunkeler; B Fireman; R Rowell; J V Selby; B M Massie; W Cooper
Journal:  Arch Intern Med       Date:  1999 Dec 13-27

Review 2.  Molecular mechanisms of human hypertension.

Authors:  R P Lifton; A G Gharavi; D S Geller
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

3.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

4.  Cardiovascular protection and blood pressure reduction: a meta-analysis.

Authors:  J A Staessen; J G Wang; L Thijs
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

5.  What is "hypertension"?

Authors:  E O'Brien; J A Staessen
Journal:  Lancet       Date:  1999-05-08       Impact factor: 79.321

Review 6.  Cost-effectiveness calculations from trials.

Authors:  E Ambrosioni; F V Costa
Journal:  J Hypertens Suppl       Date:  1996-09

7.  Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms.

Authors:  C Fatini; R Abbate; G Pepe; B Battaglini; F Gensini; G Ruggiano; G F Gensini; R Guazzelli
Journal:  Eur Heart J       Date:  2000-04       Impact factor: 29.983

Review 8.  Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease.

Authors:  J G Wang; J A Staessen
Journal:  Eur J Pharmacol       Date:  2000-12-27       Impact factor: 4.432

Review 9.  Genetic epidemiology of essential hypertension.

Authors:  I Gavras; A Manolis; H Gavras
Journal:  J Hum Hypertens       Date:  1999-04       Impact factor: 3.012

10.  Carotid thickening, cardiac hypertrophy, and angiotensin converting enzyme gene polymorphism in patients with hypertension.

Authors:  J R Jeng
Journal:  Am J Hypertens       Date:  2000-01       Impact factor: 2.689

View more
  3 in total

Review 1.  Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review.

Authors:  Amy K Mottl; David A Shoham; Kari E North
Journal:  Genet Med       Date:  2008-08       Impact factor: 8.822

2.  N-domain isoform of Angiotensin I converting enzyme as a marker of hypertension: populational study.

Authors:  Leila C V Maluf-Meiken; Fernanda B Fernandes; Danielle S Aragão; Fernanda A Ronchi; Maria C C Andrade; Maria C Franco; Andreia C S Febba; Frida L Plavnik; José E Krieger; Jose G Mill; Ricardo C C Sesso; Dulce E Casarini
Journal:  Int J Hypertens       Date:  2012-05-15       Impact factor: 2.420

Review 3.  Replicative homeostasis II: influence of polymerase fidelity on RNA virus quasispecies biology: implications for immune recognition, viral autoimmunity and other "virus receptor" diseases.

Authors:  Richard Sallie
Journal:  Virol J       Date:  2005-08-22       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.